Immunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per year — See source for full details.
$IMCR
Price history, market instrument context, member research, and related headlines in one place.
IMCR key statistics
NasdaqGSUSD
52-week range
$27.506%$40.72
Latest session $27.50–$28.45Immunocore Holdings plc (IMCR) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $28.34, up $0.52 (1.87%) from the previous close of $27.82. It has traded between $27.50 and $28.45 in the latest session. Over the past year it has ranged from $27.50 to $40.72, leaving it in the lower quarter of its 52-week range (6%). Reported volume for the session was 414.3K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $IMCR research…